Kinetic, isotherm modeling analyses of the adsorption of phenol on activated carbon/alginate composites
Abstract
Abstract The present study aimed to synthesize calcium alginate-commercial activated carbon composite beads (CA-AC) and calcium alginate-walnut shell biochar composite beads (CA-WSB) using activated carbon (AC), walnut shell biochar (WSB), and to apply its efficiency in phenol removal. The synthesized samples were characterized by energy-dispersive X-ray spectroscopy (EDS), X-ray fluorescence (XRF) spectrometry. The Brunauer, Emmett, and Teller (BET) method was used to obtain information about the samples' surface area and pore size. The kinetic model of phenol fitted well to the pseudo-second-order kinetic model. The isotherm model of phenol fitted well to the Langmuir isotherm model compared with other models. The maximum adsorption capacity was 76.92, 0.419, 8.130 1.375 mg/g for AC, WSB, CA-AC, CA-WSB. Novelty Statement Pyrolysis is among the disposal methods applied to reduce the impact of agricultural and animal wastes on the environment and human health and to ensure their management. Biochars are widely used alternative adsorbent for the removal of pollutants from wastewater. No published work has been on the walnut shell biochar (WSB) encapsulated alginate hydrogel bead for the phenol adsorption from an aqueous solution. The novelty of this study was to compare the adsorption capacity, and removal efficiencies of calcium alginate-commercial activated carbon composite beads (CA-AC) and calcium alginate-biochar composite beads (CA-WSB) prepared from walnut shells by…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.